Amy Corneli

Duke University — United States

Medicine · Health Sciences

29h-index4.4kcitations194works2.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV/AIDS Research and Interventions(75), Ethics in Clinical Research(40), Adolescent Sexual and Reproductive Health(38), HIV, Drug Use, Sexual Risk(37), Health Systems, Economic Evaluations, Quality of Life(15)

Publications194 total

Partnerships Between a University-Affiliated Clinic and Community-Based Organizations to Reach Black Men Who Have Sex With Men for PrEP Care
UNC Libraries·2025Open Access
Enhancing Cardiovascular Health in Southeastern United States for Underrepresented Racial and Ethnic Minorities With HIV: A Qualitative Inquiry Using the Health Belief Model
Journal of the Association of Nurses in AIDS Care·2025Open Access
Experiences of resilience among newly graduated nurses transitioning to practice: A qualitative study
Teaching and learning in nursing·2025
Data from Adoption of Decentralized Trial Elements in Cancer Clinical Trials Supporting FDA Approvals during COVID-19
2025Open Access
Supplementary Data from Adoption of Decentralized Trial Elements in Cancer Clinical Trials Supporting FDA Approvals during COVID-19
2025Open Access
Experiences of Resilience Among Newly Graduated Nurses Transitioning to Practice
Nurse Educator·2025· 3 cited
Moving the ACR's Reproductive Health Guidelines Into Practice
JCR Journal of Clinical Rheumatology·2025
Community-engaged adaptation and pilot testing of a mental health and substance use screening and referral process in HIV pre-exposure prophylaxis (PrEP) care in the Southern USA
PLOS mental health.·2025Open Access
Improving Community-Engaged Implementation Science: Perspectives From “Ending the HIV Epidemic” Supplement Award Cases in the United States
JAIDS Journal of Acquired Immune Deficiency Syndromes·2025· 2 cited
Lessons Learned From Engaging Healthcare Providers in Research on Implementation of HIV Preexposure Prophylaxis
JAIDS Journal of Acquired Immune Deficiency Syndromes·2025· 1 citedOpen Access
Implementation Science Methods, Challenges, and Associated Solutions: Transportable Lessons Learned and Best Practices From the Second National Meeting for Research and Community Collaboration Toward Ending the HIV Epidemic in the United States
JAIDS Journal of Acquired Immune Deficiency Syndromes·2025· 3 cited
Impact of a Multi-Institutional Initiative to Engage Students and Early-Stage Scholars From Underrepresented Racial and Ethnic Minority Groups in HIV Research: The Centers for AIDS Research Diversity, Equity, and Inclusion Pathway Initiative
UNC Libraries·2025Open Access
Barriers and Facilitators Influencing Parents’ Willingness to Follow Healthcare Provider Guidance for Addressing Behaviors Linked to Early Childhood Obesity Risk: A Qualitative Descriptive Study
Journal of Pediatric Health Care·2025· 1 cited
Adoption of Decentralized Trial Elements in Cancer Clinical Trials Supporting FDA Approvals during COVID-19
Clinical Cancer Research·2025· 3 citedOpen Access
Perspectives of Rheumatologists on the Type 1 and 2 Systemic Lupus Erythematosus Model
ACR Open Rheumatology·2024· 2 citedOpen Access
Assisting Black Patients With Decision-Making for Implantable Cardioverter Defibrillator Therapy: Qualitative Findings From the Videos to Reduce Racial Disparities in ICD Therapy via Innovative Designs (VIVID) Trial
Circulation Cardiovascular Quality and Outcomes·2024· 2 cited
The Opioid Epidemic and Faith-Based Responses in Southern Appalachia, USA: An Exploration of Factors for Successful Cross-Sector Collaboration
Journal of Religion and Health·2024· 1 cited
“I Had No Idea about This:” A Mixed-Methods Exploration of Sexual Health and HIV Prevention Needs among Black Youth in a Southern City
Adolescents·2024· 1 citedOpen Access
Implementation of a Clinician-led Medication Adherence Intervention Among Patients With Systemic Lupus Erythematosus
The Journal of Rheumatology·2024· 3 citedOpen Access
Adoption of decentralized trial elements in cancer clinical trials supporting FDA approvals during COVID-19.
Journal of Clinical Oncology·2024
page 1 of 10Next →

Frequent Co-authors

Khatija Ahmed(12), Kawango Agot(12), Lut Van Damme(10), Brian Perry(9), Kevin McKenna(7), Johan Lombaard(6), Jacob Odhiambo(6), Joseph Skhosana(6), Stuart Rennie(6), Margaret E. Bentley(5), Agnes Moses(5), Jacqueline Nkhoma(5), Yusuf Ahmed(5), Saidi Kapiga(4), Angela D. M. Kashuba(4), Meng Wang(4), Denise J. Jamieson(4), Kai Sun(4), Amanda M. Eudy(4), Lisa Criscione‐Schreiber(4)